Harbour Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,715
| Closed | -$488K | – | 117 |
|
|
2020
Q3 | $488K | Sell |
7,715
-4,060
| -34% | -$282K | 0.18% | 129 |
|
|
2020
Q2 | $906K | Sell |
11,775
-226
| -2% | -$17.3K | 0.37% | 81 |
|
|
2020
Q1 | $897K | Sell |
12,001
-2,792
| -19% | -$193K | 0.46% | 67 |
|
|
2019
Q4 | $961K | Sell |
14,793
-8,851
| -37% | -$576K | 0.37% | 82 |
|
|
2019
Q3 | $1.5M | Buy |
23,644
+3,067
| +15% | +$200K | 0.63% | 57 |
|
|
2019
Q2 | $1.39M | Buy |
20,577
+1,215
| +6% | +$79.9K | 0.6% | 61 |
|
|
2019
Q1 | $1.26M | Buy |
19,362
+2,580
| +15% | +$171K | 0.56% | 64 |
|
|
2018
Q4 | $1.05M | Buy |
16,782
+1,445
| +9% | +$101K | 0.52% | 69 |
|
|
2018
Q3 | $1.18M | Sell |
15,337
-2,440
| -14% | -$184K | 0.48% | 68 |
|
|
2018
Q2 | $1.27M | Sell |
17,777
-300
| -2% | -$21.2K | 0.54% | 70 |
|
|
2018
Q1 | $1.36M | Sell |
18,077
-330
| -2% | -$26.2K | 0.58% | 54 |
|
|
2017
Q4 | $1.32M | Buy |
18,407
+840
| +5% | +$63.8K | 0.55% | 56 |
|
|
2017
Q3 | $1.42M | Buy |
17,567
+305
| +2% | +$23.3K | 0.62% | 43 |
|
|
2017
Q2 | $1.22M | Sell |
17,262
-985
| -5% | -$65.5K | 0.61% | 49 |
|
|
2017
Q1 | $1.24M | Sell |
18,247
-50
| -0.3% | -$3.52K | 0.57% | 45 |
|
|
2016
Q4 | $1.31M | Buy |
18,297
+1,420
| +8% | +$106K | 0.94% | 26 |
|
|
2016
Q3 | $1.33M | Sell |
16,877
-3,313
| -16% | -$269K | 0.84% | 20 |
|
|
2016
Q2 | $1.68M | Buy |
20,190
+65
| +0.3% | +$5.77K | 0.95% | 19 |
|
|
2016
Q1 | $1.85M | Buy |
20,125
+1,085
| +6% | +$97.8K | 1.05% | 16 |
|
|
2015
Q4 | $1.93M | Buy |
19,040
+70
| +0.4% | +$7.28K | 1.05% | 16 |
|
|
2015
Q3 | $1.86M | Buy |
+18,970
| New | +$2.11M | 1.32% | 8 |
|
|
2015
Q2 | – | Sell |
-17,740
| Closed | -$1.94M | – | 212 |
|
|
2015
Q1 | $1.74M | Buy |
17,740
+1,805
| +11% | +$183K | 1.21% | 11 |
|
|
2014
Q4 | $1.5M | Buy |
15,935
+510
| +3% | +$52.7K | 1.08% | 11 |
|
|
2014
Q3 | $1.64M | Sell |
15,425
-630
| -4% | -$61.7K | 1.36% | 7 |
|
|
2014
Q2 | $1.33M | Buy |
16,055
+1,310
| +9% | +$102K | 1.05% | 14 |
|
|
2014
Q1 | $1.04M | Buy |
14,745
+1,295
| +10% | +$102K | 0.99% | 17 |
|
|
2013
Q4 | $1.01M | Buy |
13,450
+215
| +2% | +$15K | 0.89% | 18 |
|
|
2013
Q3 | $832K | Sell |
13,235
-193
| -1% | -$11.5K | 0.91% | 21 |
|
|
2013
Q2 | $688K | Buy |
+13,428
| New | +$700K | 0.87% | 28 |
|
Other funds holding GILD
Harbour Capital Advisors's GILD Position: Q4 2020 in Review
Harbour Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 7,715 shares — an estimated $488K sold.
Harbour Capital Advisors first reported a position in GILD in Q2 2013 and held it in 29 quarters. The position peaked at $1.93M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Harbour Capital Advisors reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Harbour Capital Advisors sold 7,715 Gilead Sciences shares in Q4 2020, an estimated $488K.
- Harbour Capital Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 29 quarters.
- Harbour Capital Advisors's Gilead Sciences position peaked at $1.93M in Q4 2015.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Harbour Capital Advisors's 13F filing for Q4 2020, filed 12 Jan 2021.